Medical Device Safety and Recalls: Vulnerabilities of Hospira LifeCare PCA3 and PCA5 Infusion Pump Systems: FDA Safety Communication

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: Medical Device Safety and Recalls: Vulnerabilities of Hospira LifeCare PCA3 and PCA5 Infusion Pump Systems: FDA Safety Communication

Safety Communication has been posted regarding the Vulnerabilities of Hospira LifeCare PCA3 and PCA5 Infusion Pump Systems.

The Hospira LifeCare PCA3 and PCA5 Infusion Pump Systems are computerized infusion pumps designed for the continuous delivery of anesthetic or therapeutic drugs. These systems can be programmed remotely through a health care facility’s Ethernet or wireless network.

The FDA and Hospira have become aware of security vulnerabilities in Hospira’s LifeCare PCA3 and PCA5 Infusion Pump Systems.  An independent researcher has released information about these vulnerabilities, including software codes, which, if exploited, could allow an unauthorized user to interfere with the pump’s functioning. An unauthorized user with malicious intent could access the pump remotely and modify the dosage it delivers, which could lead to over- or under-infusion of critical therapies.

The FDA is not aware of any patient adverse events or unauthorized device access related to these vulnerabilities.

Health care facilities can reduce the risk of unauthorized access by implementing recommendations listed in the Safety Communication.


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux